Skip to main content

Find Clinical Trials

Home
Conditions
Aspartylglucosaminuria

Clinical trial condition

Aspartylglucosaminuria

Explore clinical trials studying Aspartylglucosaminuria. Study availability and eligibility vary by location and protocol.

5 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Aspartylglucosaminuria trial results

Not Yet Recruiting

Safety and Efficacy of scAAV9/AGA Gene Therapy in Participants With Aspartylglucosaminuria (AGU)

NCT07530796

Conditions: Aspartylglucosamidase (AGA) Deficiency, Aspartylglucosamidase (AGA) deficiency, Aspartylglucosaminuria, +6 more
Locations: Not specified

View Trial Details

Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions: 3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations: CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium

View Trial Details

Completed

Longitudinal Studies of the Glycoproteinoses

NCT01891422

Conditions: Alpha Mannosidosis, Aspartylglucosaminuria, Beta Mannosidosis, +29 more
Locations: Greenwood Genetic Center North Charleston, South Carolina, United States

View Trial Details

Completed

Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders

NCT01043640

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +52 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Active, Not Recruiting

MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis

NCT02171104

Conditions: Abnormalities, Multiple, Acyl-CoA Oxidase Deficiency, Adrenoleukodystrophy With Cerebral Involvement, +85 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details